HERON THERAPEUTICS, INC. /DE/ Restructuring Reserve, Current
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Restructuring Reserve, Current of $1.09 million as of 2017-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2019-02-22
- 2017-12-31: Restructuring Reserve, Current $1.09M.
- 2016-12-31: Restructuring Reserve, Current $2.70M.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2017-12-31 | $1.09M 10-K · filed 2019-02-22 |
| 2016-12-31 | $2.70M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |